Literature DB >> 29212041

Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains.

M Gordon Joyce1, Ivelin S Georgiev1, Yongping Yang1, Aliaksandr Druz1, Hui Geng1, Gwo-Yu Chuang1, Young Do Kwon1, Marie Pancera1, Reda Rawi1, Mallika Sastry1, Guillaume B E Stewart-Jones1, Angela Zheng1, Tongqing Zhou1, Misook Choe1, Joseph G Van Galen1, Rita E Chen1, Christopher R Lees1, Sandeep Narpala1, Michael Chambers1, Yaroslav Tsybovsky2, Ulrich Baxa2, Adrian B McDermott1, John R Mascola3, Peter D Kwong4.   

Abstract

The elicitation of autologous neutralizing responses by immunization with HIV-1 envelope (Env) trimers conformationally stabilized in a prefusion closed state has generated considerable interest in the HIV-1 vaccine field. However, soluble prefusion closed Env trimers have been produced from only a handful of HIV-1 strains, limiting their utility as vaccine antigens and B cell probes. Here, we report the engineering from 81 HIV-1 strains of soluble, fully cleaved, prefusion Env trimers with appropriate antigenicity. We used a 96-well expression-screening format to assess the ability of artificial disulfides and Ile559Pro substitution (DS-SOSIP) to produce soluble cleaved-Env trimers; from 180 Env strains, 20 yielded prefusion closed trimers. We also created chimeras, by utilizing structure-based design to incorporate select regions from the well-behaved BG505 strain; from 180 Env strains, 78 DS-SOSIP-stabilized chimeras, including 61 additional strains, yielded prefusion closed trimers. Structure-based design thus enables the production of prefusion closed HIV-1-Env trimers from dozens of diverse strains. Published by Elsevier Inc.

Entities:  

Keywords:  HIV-1 vaccine; conformational stabilization; envelope trimer; prefusion closed trimer; structure-based design

Mesh:

Substances:

Year:  2017        PMID: 29212041     DOI: 10.1016/j.celrep.2017.11.016

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  33 in total

1.  Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth.

Authors:  Xuejun Chen; Tongqing Zhou; Stephen D Schmidt; Hongying Duan; Cheng Cheng; Gwo-Yu Chuang; Ying Gu; Mark K Louder; Bob C Lin; Chen-Hsiang Shen; Zizhang Sheng; Michelle X Zheng; Nicole A Doria-Rose; M Gordon Joyce; Lawrence Shapiro; Ming Tian; Frederick W Alt; Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2021-01-15       Impact factor: 31.745

2.  Overcoming Challenges in Structural Characterization of HIV-1 Envelope Glycoprotein by LC-MS/MS.

Authors:  Vera B Ivleva; Jonathan W Cooper; Frank J Arnold; Q Paula Lei
Journal:  J Am Soc Mass Spectrom       Date:  2019-05-20       Impact factor: 3.109

Review 3.  Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?

Authors:  P J Klasse; Gabriel Ozorowski; Rogier W Sanders; John P Moore
Journal:  Cell Host Microbe       Date:  2020-04-08       Impact factor: 21.023

4.  Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.

Authors:  Rui Kong; Hongying Duan; Zizhang Sheng; Kai Xu; Priyamvada Acharya; Xuejun Chen; Cheng Cheng; Adam S Dingens; Jason Gorman; Mallika Sastry; Chen-Hsiang Shen; Baoshan Zhang; Tongqing Zhou; Gwo-Yu Chuang; Cara W Chao; Ying Gu; Alexander J Jafari; Mark K Louder; Sijy O'Dell; Ariana P Rowshan; Elise G Viox; Yiran Wang; Chang W Choi; Martin M Corcoran; Angela R Corrigan; Venkata P Dandey; Edward T Eng; Hui Geng; Kathryn E Foulds; Yicheng Guo; Young D Kwon; Bob Lin; Kevin Liu; Rosemarie D Mason; Martha C Nason; Tiffany Y Ohr; Li Ou; Reda Rawi; Edward K Sarfo; Arne Schön; John P Todd; Shuishu Wang; Hui Wei; Winston Wu; James C Mullikin; Robert T Bailer; Nicole A Doria-Rose; Gunilla B Karlsson Hedestam; Diana G Scorpio; Julie Overbaugh; Jesse D Bloom; Bridget Carragher; Clinton S Potter; Lawrence Shapiro; Peter D Kwong; John R Mascola
Journal:  Cell       Date:  2019-07-25       Impact factor: 41.582

5.  Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.

Authors:  Gwo-Yu Chuang; Yen-Ting Lai; Jeffrey C Boyington; Cheng Cheng; Hui Geng; Sandeep Narpala; Reda Rawi; Stephen D Schmidt; Yaroslav Tsybovsky; Raffaello Verardi; Kai Xu; Yongping Yang; Baoshan Zhang; Michael Chambers; Anita Changela; Angela R Corrigan; Rui Kong; Adam S Olia; Li Ou; Edward K Sarfo; Shuishu Wang; Winston Wu; Nicole A Doria-Rose; Adrian B McDermott; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

6.  Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.

Authors:  Rajesh P Ringe; Pavel Pugach; Christopher A Cottrell; Celia C LaBranche; Gemma E Seabright; Thomas J Ketas; Gabriel Ozorowski; Sonu Kumar; Anna Schorcht; Marit J van Gils; Max Crispin; David C Montefiori; Ian A Wilson; Andrew B Ward; Rogier W Sanders; P J Klasse; John P Moore
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

7.  High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity.

Authors:  Ian Setliff; Andrea R Shiakolas; Kelsey A Pilewski; Amyn A Murji; Rutendo E Mapengo; Katarzyna Janowska; Simone Richardson; Charissa Oosthuysen; Nagarajan Raju; Larance Ronsard; Masaru Kanekiyo; Juliana S Qin; Kevin J Kramer; Allison R Greenplate; Wyatt J McDonnell; Barney S Graham; Mark Connors; Daniel Lingwood; Priyamvada Acharya; Lynn Morris; Ivelin S Georgiev
Journal:  Cell       Date:  2019-11-28       Impact factor: 41.582

8.  A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers.

Authors:  Lucy Rutten; Yen-Ting Lai; Sven Blokland; Daphne Truan; Ilona J M Bisschop; Nika M Strokappe; Annemart Koornneef; Danielle van Manen; Gwo-Yu Chuang; S Katie Farney; Hanneke Schuitemaker; Peter D Kwong; Johannes P M Langedijk
Journal:  Cell Rep       Date:  2018-04-10       Impact factor: 9.423

9.  Sulfono-γ-AA modified peptides that inhibit HIV-1 fusion.

Authors:  Olapeju Bolarinwa; Meng Zhang; Erin Mulry; Min Lu; Jianfeng Cai
Journal:  Org Biomol Chem       Date:  2018-10-31       Impact factor: 3.876

10.  Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains.

Authors:  Reda Rawi; Lucy Rutten; Yen-Ting Lai; Adam S Olia; Sven Blokland; Jarek Juraszek; Chen-Hsiang Shen; Yaroslav Tsybovsky; Raffaello Verardi; Yongping Yang; Baoshan Zhang; Tongqing Zhou; Gwo-Yu Chuang; Peter D Kwong; Johannes P M Langedijk
Journal:  Cell Rep       Date:  2020-11-24       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.